Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
Bates has won crea tive duties for Bristol-Myers Squibb’s diabetes drugs, following a six-month review, sources said.
Among the shops that competed for the estimated $90 million business were J. Walter Thompson, Ogilvy & Mather and Rob ert A. Becker Euro RSCG, all New York, sources said. It is unclear if incumbent MNH Healthworks, a division of Merkley Newman Harty & Partners, defended.
As part of the assignment, Bates, New York, will handle direct-to-consumer advertising for Bristol-Myers Squibb’s Glucovance and Glu co phage XR, both treatments for type 2 diabetes.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in